[Research on optimal dosage schemes in clinical experimentation with antineoplastic agents].
D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D004338:Drug Combinations / Q000008:administration & dosage; D006027:Glycosides / Q000008:administration & dosage; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D008175:Lung Neoplasms / Q000188:drug therapy; D009279:Naphthacenes / Q000008:administration & dosage; D009369:Neoplasms / Q000188:drug therapy*
D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D004338:Drug Combinations; D006027:Glycosides; D009279:Naphthacenes; D003561:Cytarabine; D003630:Daunorubicin
La ricerca degli schemi posologici ottimali nella sperimantazione clinica di farmaci antiblastici.